Medical Oncology

, Volume 28, Issue 1, pp 265–269 | Cite as

Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia

  • Ling-Na Ni
  • Jian-Yong Li
  • Kou-Rong Miao
  • Chun Qiao
  • Su-Jiang Zhang
  • Hai-Rong Qiu
  • Si-Xuan Qian
Original paper

Abstract

The human multidrug resistance gene (MDR1, ABCB1) codes for P-glycoprotein (P-gp) that affects the pharmacokinetics of many drugs. MDR1 single nucleotide polymorphisms (SNPs) are associated with drug clearance. Imatinib is a substrate of P-gp-mediated efflux. We investigated the MDR1 T1236C, G 2677T/A, and C3435T polymorphism in 52 patients with chronic myeloid leukemia treated with imatinib. The distribution of MDR1 1236, 2677, or 3435 genotypes was significantly different between the resistance patients and sensitivity patients. The resistance incidence correlated with the number of T alleles at locus 1236 and 3435. Resistance was higher for patients homozygous for the 1236T allele when compared to patients with CT/CC genotype groups (75% vs. 31.3%, P = 0.004). For the G2677T/A polymorphism, a better complete cytogenetic remission was observed for patients with genotype AG/AT/AA, when compared to other genotype groups (TT/GT/GG, P = 0.02). Patients with 3435 TT/CT genotypes showed a higher resistance when compared with patients with CC genotype (59.4% vs. 25%, P = 0.023). In conclusion, determination of 1236T, C3435T, and G2677T MDR1 polymorphisms might be useful in response prediction to therapy with imatinib in patients with CML.

Keywords

Chronic myeloid leukemia P-glycoprotein; MDR1 Polymorphism Imatinib 

References

  1. 1.
    Talpaz M, Shah NP, Kantarjian H, et al. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. N Engl J Med. 2006;354(24):2531–41.PubMedCrossRefGoogle Scholar
  2. 2.
    Dulucq S, Bouchet S, Turcq B, et al. Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia. Blood. 2008;112(5):2024–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, et al. A “silent” polymorphism in the MDR1 gene changes substrate specificity. Science. 2007;315(5811):525–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Hoffmeyer S, Burk O, von Richter O, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A. 2000;97(7):3473–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Gurney H, Wong M, Balleine RL, et al. Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotype. Clin Pharmacol Ther. 2007;82(1):33–40.PubMedCrossRefGoogle Scholar
  6. 6.
    Kimchi-Sarfaty C, Marple AH, Shinar S, et al. Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene. Pharmacogenomics. 2007;8(1):29–39.PubMedCrossRefGoogle Scholar
  7. 7.
    Jamroziak K, Mlynarski W, Balcerczak E, et al. Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur J Haematol. 2004;72(5):314–21.PubMedCrossRefGoogle Scholar
  8. 8.
    Pawlik A, Baskiewicz-Masiuk M, Machalinski B, et al. Involvement of C3435T and G2677T multidrug resistance gene polymorphisms in release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. Eur J Pharmacol. 2005;528(1–3):27–36.PubMedCrossRefGoogle Scholar
  9. 9.
    Tang K, Ngoi SM, Gwee PC, et al. Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics. 2002;12(6):437–50.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Ling-Na Ni
    • 1
  • Jian-Yong Li
    • 1
  • Kou-Rong Miao
    • 1
  • Chun Qiao
    • 1
  • Su-Jiang Zhang
    • 1
  • Hai-Rong Qiu
    • 1
  • Si-Xuan Qian
    • 1
  1. 1.Department of Hematology, Jiangsu Province Hospital, The First Affiliated Nanjing Medical University HospitalNanjing Medical UniversityNanjingChina

Personalised recommendations